THERACLION announced the treatment of varicose veins patients with SONOVEIN for the first time in the United States (US). The study has been approved by the FDA (Food and Drug Administration) a few months ago. Since then, Theraclion has installed its SONOVEIN platform and trained physicians.

The first patients have been treated by Dr. Steven Elias, Dr. Nicos Labropoulos and Dr. Antonios Gasparis, all three internationally recognized vein specialists with more than 30 years of experience. This trial is in line with Theraclion's strategy to focus on key markets.